Our 2024/25 Kit Sale is now on - with up to 40% off our range of Official Umbro Replica Kits! Now is the time to complete the look for this season, with an exciting conclusion to the campaign in store ...

Gian Piero Gasperini warns how Club Brugge can damage Atalanta in the Champions League play-off and admits to feeling disappointed at missing out on a direct route to the last 16. The first leg ...

Da valutare C'è apprensione in casa Atalanta per le condizioni di Lookman, dopo l'infortunio al ginocchio rimediato ieri in allenamento in vista della sfida di Champions col Barcellona.

Orlando City SC Unveil 2024-25 Legacy Kit From adidas Celebrating their 10th anniversary in MLS, Orlando City SC have unveiled the ‘Legacy Kit’, which will be in use for the 2024 & 25 seasons. The ...

Club Brugge will host Atalanta in the first leg of the Round of 32 clash of the ongoing UEFA Champions League 2024-25 at the Jan Breydelstadion in Belgium on Wednesday, February 12. (More Football ...

Goal! Club Brugge 2, Atalanta 1. Gustaf Nilsson (Club Brugge) converts the penalty with a right footed shot to the centre of the goal. Attempt saved. Juan Cuadrado (Atalanta) left footed shot from ...

Atalanta remained third in the standings on 51 points, four off leaders Napoli and three behind Inter Milan, both with a game in hand. Cagliari are 13th with 25 points.

Club Brugge scored with a disputed penalty kick in stoppage time to beat Atalanta 2-1 in their UEFA Champions League playoff first leg on Wednesday (February 12, 2025). A late light-touch clash ...

Atalanta manager Gian Piero Gasperini said a lack of fit strikers had hit them hard as he sought to explain their 0-0 draw with mid-table Cagliari on Saturday. With Cagliari sitting 13th in the ...

VERONA, Italy, Feb 8 (Reuters) - Atalanta thrashed lowly Hellas Verona ... Ederson increased the advantage in the 37th minute. The 25-year-old capitalised on a costly mistake by Verona midfielder ...

Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small interfering RNA (siRNA) candidates in epilepsy and Huntington’s disease.